Amerise Biosciences Ltd
BSE: 531681
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.00 | 0.00-100.0% | 0.08 | 0.00 | 0.00-100.0% | 0.06-66.1% | 0.19 |
| Other Income | 0.00 | 0.00 | 0.00-100.0% | 0.04-33.5% | 0.07 | 0.00 | 0.00 |
| Total Income | 0.00 | 0.00-100.0% | 0.08+76.4% | 0.04-33.5% | 0.07+6.0% | 0.06-66.1% | 0.19 |
| EXPENSES | |||||||
| Expenditure | 0.06-29.3% | 0.08+355.3% | 0.02-49.1% | 0.04-67.9% | 0.11+52.9% | 0.07-12.5% | 0.08 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||||
| PBT | -0.06+29.3% | -0.08-233.0% | 0.06+532.0% | 0.01+122.9% | -0.04-422.2% | -0.01-107.6% | 0.11 |
| Net Profit | -0.06+29.3% | -0.08-233.0% | 0.06+532.0% | 0.01+122.9% | -0.04-422.2% | -0.01-107.6% | 0.11 |
| KEY METRICS | |||||||
| OPM % | — | — | 77.40% | — | — | -12.72%-69.05pp | 56.33% |
| NPM % | — | — | 77.40%+55.80pp | 21.60%+84.27pp | -62.67%-49.95pp | -12.72%-69.05pp | 56.33% |
| EPS | -0.01-200.0% | 0.01+0.0% | 0.01 | 0.00-100.0% | 0.01 | 0.00-100.0% | 0.02 |
Corporate Events
Board MeetingAMERISE
202630Oct
Board Meeting
The Board of Directors considered and approved Un-audited fi…
BSE Filing ↗ Board MeetingAMERISE
202624Sep
Board Meeting
To receive, consider and adopt the audited financial stateme…
BSE Filing ↗ Board MeetingAMERISE
20263Aug
Board Meeting
The Board of Directors considered and approved Un-audited fi…
BSE Filing ↗ Board MeetingAMERISE
202423May
Board Meeting
Approve and take on record the Audited Standalone Financial …
BSE Filing ↗